Home » Topics » BioWorld Science

BioWorld Science
RSS

Researchers present new F-BODIPY dyes for cancer

Jan. 11, 2022

Sato Pharmaceutical patents new HPGDS inhibitors

Jan. 11, 2022

Century and Bristol Myers Squibb collaborate to develop iPSC-derived allogeneic cell therapies

Jan. 11, 2022

Autobahn Therapeutics discloses thyroid hormone receptor agonists

Jan. 11, 2022

InflaRx advances oral C5aR inhibitor INF-904 toward clinic

Jan. 11, 2022

Regulation of SWI/SNF complex SMARCA2/4 subunits for treating enhancer-addicted prostate cancer

Jan. 11, 2022

Researchers find novel PTSD-related biomarkers

Jan. 11, 2022

Immunization with MERS-CoV RNA replicons proves to be safe and effective in mice

Jan. 11, 2022

New blood sugar regulatory hormone discovered

Jan. 11, 2022

Cullinan collaborates with Mount Sinai to develop HPK1 protein degraders for cancer

Jan. 10, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 29, 2026.
TROP2 ADCs progress into first-line for lung, breast cancers
BioWorld
Multiple updates on TROP2-directed antibody-drug conjugates (ADCs) for lung and breast cancers highlight both progress made and opportunities for improvement for...
New evidence links autoimmunity to long COVID symptoms
BioWorld
Recent findings are reshaping current understanding of the post-infection landscape of SARS-CoV-2. Although previous studies had already suggested that...
Will Ovid’s golden age of KCC2 metamorph CNS?
BioWorld
The “deep dive” April 8 by Ovid Therapeutics Inc. into potassium-chloride co-transporter 2 (KCC2) research included company officials and independent experts in...
Breakthrough as GSK’s bepirovirsen clears 19% of chronic hep B infections
BioWorld
GSK plc has announced a breakthrough in the treatment of chronic hepatitis B, reporting a functional cure rate of 19% across two phase III trials of its antisense...